drugset / Trial / NCT03263520
Impact of the Use of Nandrolone on the Treatment of Malnutrition Induced by Cancer
RandomizedParallel-groupDouble-blindSupportive care
Summary
Compare the use of nandrolone associated with corticosteroid for the treatment of cancer-induced malnutrition to treatment with corticosteroids alone in patients with tumors in the high gastro-intestinal tract, liver, pancreas and bile ducts in palliative treatment.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-08-30
- Completion
- 2017-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nandrolone Decanoate | Small molecule | 25 mg | Intramuscular |
| Subject | Nandrolone Decanoate | Small molecule | 50 mg | Intramuscular |
| Comparator | Dexamethasone | Small molecule | 4 mg | Oral |